diethylnitrosamine has been researched along with niacinamide in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schoental, R | 1 |
| Kamiya, T; Sakamoto, M; Yanagi, S | 1 |
| Jirtle, RL; Michalopoulos, G; Novicki, DL; Novotny, A; Rosenberg, MR | 1 |
| Denda, A; Emi, Y; Konishi, Y; Mikami, S; Nakae, D; Ohnishi, T; Takahashi, S | 1 |
| Denda, A; Emi, Y; Konishi, Y; Mikami, S; Nakae, D; Ohnishi, T; Takahashi, S; Yokose, Y | 1 |
| Jackson, TM; Kirkland, JB; Rawling, JM; Roebuck, BD | 1 |
| Bhattacharya, RK; Choudhury, S; Krishna, M | 1 |
| Carr, BI; Cavallini, A; D'Alessandro, R; Refolo, MG; Wang, M; Wang, Z | 1 |
| Allemeersch, J; Carmeliet, P; Casteleyn, C; Colle, I; Coulon, S; Geerts, A; Heindryckx, F; Libbrecht, L; Stassen, JM; Terrie, E; Van Vlierberghe, H | 1 |
| Chan, C; Felsher, DW; Gamrekelashvili, J; Greten, TF; Hewitt, S; Kapanadze, T; Kapoor, V; Korangy, F; Ma, C; Manns, MP; Zender, L; Zhao, F | 1 |
| Barbeiro, DF; Bida, PM; Carrilho, FJ; Coelho, AM; Cogliati, B; D'Albuquerque, LA; Kubrusly, MS; Mazo, DF; Oliveira, CP; Pereira, IV; Souza, HP; Stefano, JT; Torres, MM; Xerfan, MP | 1 |
| Elsadek, B; Kratz, F; Mansour, A; Saleem, T; Warnecke, A | 1 |
| Baglioni, M; Baron Toaldo, M; Bolondi, L; Cescon, M; Giovannini, C; Gramantieri, L | 1 |
| Abdelghany, RH; El-Ahwany, E; Goda, R; Helal, NS; Mahmoud, AAA; Saber, S | 1 |
14 other study(ies) available for diethylnitrosamine and niacinamide
| Article | Year |
|---|---|
The role of nicotinamide and of certain other modifying factors in diethylnitrosamine carcinogenesis: fusaria mycotoxins and "spontaneous" tumors in animals and man.
Topics: Animals; Diethylnitrosamine; Female; Fusarium; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Mycotoxins; Neoplasms, Experimental; Neoplasms, Multiple Primary; Niacinamide; Nitrosamines; Nose Neoplasms; Pregnancy; Rats; Trichothecenes | 1977 |
Inhibitory effects of niacin and its analogues on induction of ornithine decarboxylase activity by diethylnitrosamine in rat liver.
Topics: Aldehydes; Animals; Diethylnitrosamine; Enzyme Induction; Liver; Male; Niacin; Niacinamide; Nicotinic Acids; Nicotinyl Alcohol; Ornithine Decarboxylase; Picolines; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Inbred Strains; Tyrosine Transaminase | 1987 |
Promoting effect of nicotinamide on the development of renal tubular cell tumors in rats initiated with diethylnitrosamine.
Topics: Animals; Body Weight; Cocarcinogenesis; Diethylnitrosamine; Kidney Neoplasms; Kidney Tubules; Male; Microscopy, Electron; Niacinamide; Nitrosamines; Rats; Rats, Inbred F344 | 1985 |
Possible role of poly(ADP-ribose) polymerase on the early stage of liver carcinogenesis by diethylnitrosamine in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Benzamides; Diethylnitrosamine; Dimethyl Sulfoxide; Enzyme Activation; gamma-Glutamyltransferase; Liver Neoplasms; NAD+ Nucleosidase; Niacinamide; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Inbred Strains; Thymidine | 1983 |
Enhancement of DEN initiation of liver carcinogenesis by inhibitors of NAD+ ADP ribosyl transferase in rats.
Topics: Animals; Benzamides; Diethylnitrosamine; DNA Repair; gamma-Glutamyltransferase; Liver; Liver Neoplasms; Male; NAD+ Nucleosidase; Necrosis; Niacinamide; Nucleotidyltransferases; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Inbred Strains; Thymidine | 1984 |
Large supplements of nicotinic acid and nicotinamide increase tissue NAD+ and poly(ADP-ribose) levels but do not affect diethylnitrosamine-induced altered hepatic foci in Fischer-344 rats.
Topics: Adenosine Diphosphate Ribose; Animals; Diethylnitrosamine; Food, Fortified; Glutathione Transferase; Kidney; Liver; Lung; Male; Myocardium; NAD; Niacin; Niacinamide; Rats; Rats, Inbred F344 | 1995 |
Modulation of NDEA activated ras expression and protein kinase C activity by nicotinamide.
Topics: Alkylating Agents; Animals; Cytosol; Diethylnitrosamine; Diglycerides; Enzyme Activation; Gene Expression Regulation; Genes, ras; Liver; Male; Niacinamide; Protein Kinase C; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction | 1999 |
c-Met-Akt pathway-mediated enhancement of inhibitory c-Raf phosphorylation is involved in vitamin K1 and sorafenib synergy on HCC growth inhibition.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cyclic AMP-Dependent Protein Kinases; Diethylnitrosamine; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Liver Neoplasms, Experimental; MAP Kinase Kinase Kinases; Niacinamide; Phenylurea Compounds; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Proto-Oncogene Proteins c-raf; Pyridines; Rats; Rats, Inbred F344; Signal Transduction; Sorafenib; Vitamin K 1 | 2011 |
The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine-induced mouse model.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Hepatocellular; Diethylnitrosamine; Disease Models, Animal; Drug Therapy, Combination; Liver Neoplasms; Mice; Mice, Knockout; Mice, Transgenic; Neoplasm Metastasis; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Placenta Growth Factor; Pregnancy Proteins; Sorafenib; Treatment Outcome | 2013 |
Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Diethylnitrosamine; Disease Models, Animal; Granulocyte-Macrophage Colony-Stimulating Factor; Heterografts; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myeloid Cells; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-myc; Sorafenib | 2013 |
Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model.
Topics: Animals; Chaperonin 60; Diet, High-Fat; Diethylnitrosamine; Disease Models, Animal; Fibrillar Collagens; Glutathione Transferase; HSP90 Heat-Shock Proteins; Interleukin-10; Interleukin-6; Liver Cirrhosis; Matrix Metalloproteinase 9; Mitochondria, Liver; Niacinamide; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenylurea Compounds; Polarography; Protein Kinase Inhibitors; Rats, Sprague-Dawley; RNA, Messenger; Sorafenib; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transcription Factors | 2015 |
The antitumor activity of a lactosaminated albumin conjugate of doxorubicin in a chemically induced hepatocellular carcinoma rat model compared to sorafenib.
Topics: Animals; Antibiotics, Antineoplastic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Diethylnitrosamine; Doxorubicin; Humans; Kaplan-Meier Estimate; Liver; Liver Neoplasms, Experimental; Male; Niacinamide; Phenylurea Compounds; Rats; Rats, Wistar; Serum Albumin; Sorafenib; Survival Rate | 2017 |
Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Proliferation; Cytokines; Diethylnitrosamine; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Hepatocytes; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Rats, Wistar; Scorpions; Signal Transduction; Sorafenib; Spider Venoms; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cyclin D1; Diethylnitrosamine; Fosinopril; Liver Neoplasms, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; Niacinamide; Perindopril; Phenylurea Compounds; Phosphorylation; Renin-Angiotensin System; Signal Transduction; Sorafenib; Time Factors; Transcription Factor RelA; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2018 |